Cystic fibrosis
An inherited disorder of the exocrine glands that primarily affects the gastrointestinal tract and respiratory systems and is usually characterized by chronic obstructive lung disease, exocrine pancreatic insufficiency, and abnormally elevated sweat electrolytes.
-
Site of disease:
Lung Pancreas Whole body -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Liver dysfunction liver failure portal hypertension intestinal atresia hepatomegaly -
Concurrent disease:
Related Drugs
TOBRAMYCIN- tobramycin_solution
Indication: Tobramycin inhalation solution is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa 1 Burkholderia cepacia [see Clinical Studies ( 14 Tobramycin inhalation solution is an inhaled aminoglycoside antibacterial indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa 1 Safety and efficacy have not been demonstrated in patients under the age of six years, patients with a forced expiratory volume in one second (FEV 1 Burkholderia cepacia 1.
Manufacturer:
Teva Pharmaceuticals USA, Inc.